These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8059796)

  • 1. Treatment of bone and joint infections utilizing a third-generation cephalosporin with an outpatient drug delivery device. HIAT Study Group.
    Mauceri AA
    Am J Med; 1994 Aug; 97(2A):14-22. PubMed ID: 8059796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of serious infections with cefotaxime utilizing an outpatient drug delivery device: global analysis of a large-scale, multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):34-42. PubMed ID: 8059800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient antibiotic therapy for elderly patients. HIAT Study Group.
    Angel JV
    Am J Med; 1994 Aug; 97(2A):43-9. PubMed ID: 8059801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime.
    Morales JO; Von Behren L
    Am J Med; 1994 Aug; 97(2A):9-13. PubMed ID: 8059803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients.
    Morales JO; Snead H
    Am J Med; 1994 Aug; 97(2A):28-33. PubMed ID: 8059798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):23-7. PubMed ID: 8059797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime treatment in patients with osteomyelitis and septic arthritis: a multicenter study.
    Mader JT; Reinarz JA; LeFrock JL
    Clin Ther; 1982; 5 Suppl A():10-8. PubMed ID: 6293713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with cefotaxime in the treatment of serious bone and joint infections.
    LeFrock JL; Carr BB
    Rev Infect Dis; 1982; 4 Suppl():S465-71. PubMed ID: 6294800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing costs and hospital stay for pneumonia with home intravenous cefotaxime treatment: results with a computerized ambulatory drug delivery system.
    Williams DN
    Am J Med; 1994 Aug; 97(2A):50-5. PubMed ID: 8059802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime therapy for patients with osteomyelitis and septic arthritis.
    Mader JT; LeFrock JL; Hyams KC; Molavi A; Reinarz JA
    Rev Infect Dis; 1982; 4 Suppl():S472-80. PubMed ID: 6294801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.
    LeFrock J; Mader J; Smith B; Carr B
    Infection; 1985; 13 Suppl 1():S50-5. PubMed ID: 4055056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issues.
    Craven PC
    Hosp Formul; 1993 Jan; 28 Suppl 1():41-5. PubMed ID: 10123838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.
    Putz PA
    Am J Med; 1993 Mar; 94(3A):177S-181S. PubMed ID: 8452177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy of bone and joint infections in children: proposals of the French Pediatric Infectious Disease Group.
    Lorrot M; Gillet Y; Gras Le Guen C; Launay E; Cohen R; Grimprel E
    Arch Pediatr; 2017 Dec; 24(12S):S36-S41. PubMed ID: 29290233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Choice of first-line antibiotic therapy in the treatment of bone and joint infections in children].
    Badelon O; Bingen E; Sauzeau C; Lambert-Zechovsky N; de Ribier A; Bensahel H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):746-9. PubMed ID: 3054761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program.
    Williams DN; Bosch D; Boots J; Schneider J
    Clin Ther; 1993; 15(1):169-79; discussion 168. PubMed ID: 8458046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of fleroxacin in the treatment of bone and joint infections.
    Liu YC; Cheng DL; Liu CY; de Garis ST; Lin HH; Hsieh TL; Yen MY; Wang RS; Chen YS
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):514-9. PubMed ID: 1488710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
    LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
    Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.